Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

gsk.com

Press releases

Get the latest updates from Press releases directly as they happen.

Follow now 558 followers

Latest posts

Last updated about 2 hours ago

Luke Miels appointed CEO designate for GSK

15 days ago

Luke to assume full responsibilities as CEO from 1st January 2026

GSK to submit label update for Wellcovorin (leucovorin) at US FDA’s request

22 days ago

GSK confirmed today that it will submit a supplemental New Drug Application...

GSK to invest $30 billion in R&D and Manufacturing in the United States over next 5 years

27 days ago

New facilities will bridge R&D and manufacturing across both the US and...

GSK to showcase new research from its broad respiratory portfolio at the European Respiratory Society (ERS) Congress 2025

29 days ago

60+ abstracts highlight GSK ambition in respiratory diseases to reduce exacerbations, prevent...

Gepotidacin accepted for priority review by the US FDA for the oral treatment of uncomplicated urogenital gonorrhoea

2 months ago

Submission supported by positive phase III data in patients with uncomplicated urogenital...

GSK provides update on US settlement of CureVac/BioNTech mRNA patent litigation

2 months ago

CureVac will make an upfront settlement of $370 million to GSK

GSK delivers continued strong performance

3 months ago

Q2 2025 performance highlights

GSK highlights new findings on Dementia and Alzheimer’s Disease at AAIC 2025, building on leadership in immunology and inflammation

3 months ago

Real-world data shows an association between Recombinant Zoster Vaccine (RZV) and potential...

GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

3 months ago

Includes license for potential best-in-class PDE3/4 inhibitor (HRS-9821) in clinical development for...

Blenrep (belantamab mafodotin) combinations approved in EU for treatment of relapsed/refractory multiple myeloma

3 months ago

Sixth regulatory approval for Blenrep combinations with applications under review in all...